Potential benefits of berberine in the management of perimenopausal syndrome

Oxidative Medicine and Cellular Longevity
Cristiana CalicetiArrigo Francesco Giuseppe Cicero

Abstract

Cardiovascular diseases are one of the leading causes of morbidity and mortality in women after menopause and 56% of all causes of death in Western European countries. Nowadays, with increasing life span, women spend approximately one-third of their life-time in postmenopausal state; therefore, the development of new strategies to improve the prevention and treatment of menopause-associated pathologies is important topic in clinical practice. The studies to assess the safety of hormone replacement therapy in women with estrogen deficiency have not been conclusive due to the relative contraindications; therefore, hormone replacement therapy is prescribed only in selected cases and for a limited time. For this reason, today women are encouraged to use naturally available compounds to prevent or to attenuate menopausal symptoms and correlated pathologies, with fewer side effects. Among these compounds, berberine, an isoquinoline alkaloid derived from plants of the generis Berberis, has been recognized as being capable of decreasing oxidative stress, LDL, triglycerides, and insulin resistance and of improving the mood. This review describes the cellular and clinical effects associated with the use of berberine, which suggest that t...Continue Reading

References

Sep 17, 1994·Lancet·J L Witztum
Jan 1, 1993·Biology of the Neonate·E Chan
May 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C K Sen, L Packer
Oct 1, 1996·Hypertension·S TaddeiA Salvetti
Jan 1, 1996·Free Radical Biology & Medicine·I Ceballos-PicotB Descamps-Latscha
Mar 29, 2001·Planta medica·L D KongR X Tan
Oct 27, 2001·Endocrine Research·M MaynarM J Caballero
Jul 13, 2002·Clinical Chemistry and Laboratory Medicine : CCLM·Lúcia C N ErberichMarileia Scartezini
Aug 13, 2002·Current Opinion in Clinical Nutrition and Metabolic Care·Dominique Bonnefont-Rousselot
Jun 6, 2003·European Heart Journal·R M ConroyUNKNOWN SCORE project group
Nov 18, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Wei-Jia KongJian-Dong Jiang
Dec 1, 2005·Trends in Immunology·Charles L RaisonAndrew H Miller
Dec 6, 2005·Maturitas·Salvatore Santo SignorelliSarina Caschetto
Mar 16, 2006·JAMA : the Journal of the American Medical Association·Eric L DingSimin Liu
Mar 17, 2006·Methods and Findings in Experimental and Clinical Pharmacology·H-W XinY-Y Liu
Oct 6, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Giulio CeolottoAngelo Avogaro
Nov 1, 2007·American Journal of Physiology. Endocrinology and Metabolism·Jun YinJianping Ye
Jul 1, 2008·European Journal of Pharmacology·Shrinivas K Kulkarni, Ashish Dhir
Jul 22, 2008·Metabolism: Clinical and Experimental·Wei-Jia KongJian-Dong Jiang
Sep 12, 2008·Antioxidants & Redox Signaling·Randall S FreyAsrar B Malik
Dec 9, 2008·Metabolism: Clinical and Experimental·Wei-Jia KongJian-Dong Jiang

❮ Previous
Next ❯

Citations

Nov 20, 2018·Journal of Cellular and Molecular Medicine·Jie FanRanji Cui
Jan 15, 2019·Phytotherapy Research : PTR·Mohsen Imenshahidi, Hossein Hosseinzadeh
Apr 27, 2020·Frontiers of Medicine·Danyang SongDaiming Fan
Jan 10, 2020·Oxidative Medicine and Cellular Longevity·Giorgio AquilaPaola Rizzo
Jul 12, 2020·International Journal of Molecular Sciences·José L Sánchez-GloriaFausto Sánchez-Muñoz

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy
glycation
nuclear translocation

Related Concepts

Related Feeds

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

The Journal of Steroid Biochemistry and Molecular Biology
Ana C MoreiraVilma A Sardão
Climacteric : the Journal of the International Menopause Society
G JonusieneJ Bancroft
Annals of the Academy of Medicine, Singapore
Citra Nurfarah MattarMahesh Choolani
© 2021 Meta ULC. All rights reserved